Mumbai: India’s primary market is set for a heavy inflow of healthcare companies, including several in-vitro fertilization (IVF) chains, next year, with public offerings worth around ₹20,000 crore expected to hit the streets. A mix of major hospital groups and fast-growing IVF platforms have filed or are about to file draft papers, according to investment […]
